Posts by Milind Javle
MicroRNAs, Focus of Nobel Prize, Highlight Untapped Potential
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2–p53 Antagonist Suitable for Intermittent Dose Schedules
How do plastics, including microplastics and plastic-associated chemicals, affect human health?
Where do you stand?
(From Happiness equation, Neil Pasricha)
Accelerated approvals: Early-phase success or premature authorization?
The pitfalls of accelerated approvals: failure rate of post-marketing confirmatory trials has increased from 13.8% duringthe 2007–2015 period to 33.3% during the 2016–2023 period.
Caring for carers of people with cancer
Patient Enrollment to Industry-Sponsored Versus Federally-Sponsored Cancer Clinical Trials.
Why federally funded trials are falling short of industry sponsored trials?